Tri-Cira Lo 21 0.25 mg (Norgestimate TABLET) 0.25 MG

TRI-CIRA LO 21 0.25 MG tablets contain norgestimate, a progestin used for hormonal contraception. This oral medication is designed to prevent ovulation and is available in a 21-day pack.

Strength

0.25 MG

Pack Size

Manufacturer / TM Owner

APOTEX INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

TRI-CIRA LO 21 0.25 MG tablets are primarily used for birth control. The active ingredient, norgestimate, works by preventing ovulation and altering the cervical mucus to hinder sperm movement. This medication is part of a combined oral contraceptive regimen, typically taken for 21 consecutive days followed by a 7-day break. It is important to follow the prescribed schedule for effective contraception.

Side Effects

Common effects of TRI-CIRA LO 21 0.25 MG tablets may include changes in menstrual bleeding patterns, such as lighter or shorter periods. Some users may experience nausea, breast tenderness, or headaches. These effects vary among individuals and are generally mild. If any effects persist or worsen, it is advisable to consult a healthcare provider.

Precautions & Warnings

TRI-CIRA LO 21 0.25 MG tablets should be stored at room temperature, away from moisture and heat. Keep the medication out of reach of children and pets. It is important to follow the prescribed dosage and schedule. Do not use this medication if you are allergic to norgestimate or any of its components. Inform your healthcare provider about any medical conditions or medications you are currently taking.

Avoid Interactions

TRI-CIRA LO 21 0.25 MG tablets may interact with certain medications, including antibiotics, anticonvulsants, and HIV medications. These interactions can affect the effectiveness of the contraceptive. Alcohol consumption should be moderated, as it may exacerbate certain side effects. Always consult a healthcare provider before starting or stopping any medication while using TRI-CIRA LO 21 0.25 MG tablets.

Frequently Asked Questions

TRI-CIRA LO 21 0.25 MG tablets are used for hormonal contraception, primarily to prevent pregnancy by inhibiting ovulation and altering cervical mucus.

TRI-CIRA LO 21 0.25 MG tablets are typically taken orally for 21 consecutive days, followed by a 7-day break. Follow the prescribed schedule for effective contraception.

Common side effects may include changes in menstrual bleeding, nausea, breast tenderness, and headaches. These effects vary among individuals and are generally mild.

Moderate alcohol consumption is advised, as it may exacerbate certain side effects. Consult a healthcare provider for personalized advice.

If you miss a dose, take it as soon as you remember. If it is close to the time for your next dose, skip the missed dose and continue with your regular schedule. Follow the prescribed guidelines for missed doses.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.